Search Results - "QUANZ, Maria"
-
1
Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance
Published in Molecular cancer therapeutics (01-11-2018)“…The lactate transporter /monocarboxylate transporter 1 (MCT1) plays a central role in tumor cell energy homeostasis. In a cell-based screen, we identified a…”
Get full text
Journal Article -
2
Novel Class of Potent and Cellularly Active Inhibitors Devalidates MTH1 as Broad-Spectrum Cancer Target
Published in ACS chemical biology (18-08-2017)“…MTH1 is a hydrolase responsible for sanitization of oxidized purine nucleoside triphosphates to prevent their incorporation into replicating DNA. Early tool…”
Get full text
Journal Article -
3
Hyperactivation of DNA-PK by double-strand break mimicking molecules disorganizes DNA damage response
Published in PloS one (21-07-2009)“…Cellular response to DNA damage involves the coordinated activation of cell cycle checkpoints and DNA repair. The early steps of DNA damage recognition and…”
Get full text
Journal Article -
4
A Preclinical Study Combining the DNA Repair Inhibitor Dbait with Radiotherapy for the Treatment of Melanoma
Published in Neoplasia (New York, N.Y.) (01-10-2014)“…Abstract Melanomas are highly radioresistant tumors, mainly due to efficient DNA double-strand break (DSB) repair. Dbait (which stands for DNA strand break…”
Get full text
Journal Article -
5
DNA-PK target identification reveals novel links between DNA repair signaling and cytoskeletal regulation
Published in PloS one (25-11-2013)“…The DNA-dependent protein kinase (DNA-PK) may function as a key signaling kinase in various cellular pathways other than DNA repair. Using a two-dimensional…”
Get full text
Journal Article -
6
Structural Evidence for Isoform-Selective Allosteric Inhibition of Lactate Dehydrogenase A
Published in ACS omega (09-06-2020)“…Lactate dehydrogenase A (LDHA) is frequently overexpressed in tumors, thereby sustaining high glycolysis rates, tumor growth, and chemoresistance…”
Get full text
Journal Article -
7
Small-Molecule Drugs Mimicking DNA Damage: A New Strategy for Sensitizing Tumors to Radiotherapy
Published in Clinical cancer research (15-02-2009)“…Purpose: Enhanced DNA repair activity is often associated with tumor resistance to radiotherapy. We hypothesized that inhibiting DNA damage repair would…”
Get full text
Journal Article -
8
Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models
Published in Oncotarget (25-09-2018)“…Despite the recent advances in the treatment of ovarian cancer, it remains an area of high unmet medical need. Epithelial ovarian cancer is associated with…”
Get full text
Journal Article -
9
Heat Shock Protein 90α (Hsp90α) Is Phosphorylated in Response to DNA Damage and Accumulates in Repair Foci
Published in The Journal of biological chemistry (16-03-2012)“…DNA damage triggers a complex signaling cascade involving a multitude of phosphorylation events. We found that the threonine 7 (Thr-7) residue of heat shock…”
Get full text
Journal Article -
10
Kinesin KIFC1 actively transports bare double-stranded DNA
Published in Nucleic acids research (01-05-2013)“…During the past years, exogenous DNA molecules have been used in gene and molecular therapy. At present, it is not known how these DNA molecules reach the cell…”
Get full text
Journal Article -
11
Abstract 1049: Pharmacological characterization of a novel potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor with robust in vivo efficacy and increased therapeutic index with niacin supplementation
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract Nicotinamide adenine dinucleotide (NAD+) is an important metabolite and cofactor for a number of cellular processes including genomic stability and…”
Get full text
Journal Article -
12
Abstract 1780: Anetumab ravtansine has single-agent activity in mesothelin-expressing human ovarian cancer models and potentiates the activity of chemotherapeutics and targeted agents
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Ovarian cancer remains an area of high unmet medical need, with 239,000 patients newly diagnosed per year. Here we describe the mesothelin-targeting…”
Get full text
Journal Article -
13
Inhibition of DNA damage repair by artificial activation of PARP with siDNA
Published in Nucleic acids research (01-08-2013)“…One of the major early steps of repair is the recruitment of repair proteins at the damage site, and this is coordinated by a cascade of modifications…”
Get full text
Journal Article -
14
Kinesin KIFC1 Actively Transports Double-Stranded DNA in Eukaryotic Cells
Published in Biophysical journal (28-01-2014)Get full text
Journal Article -
15
Abstract 1807: Anti-tumor activity of a novel structural class of NAMPT inhibitor-based ADCs in models of hematologic and solid tumor indications
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Nicotinamide phosphoribosyl-transferase (NAMPT) is the rate-limiting enzyme in the salvage pathway, generating nicotinamide adenine dinucleotide (NAD)…”
Get full text
Journal Article -
16
Abstract 5226: Novel class of potent and selective inhibitors efface MTH1 as broad-spectrum cancer target
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Malignant transformation is accompanied by increased reactive oxygen species (ROS) known to promote carcinogenesis and damage free nucleotides and…”
Get full text
Journal Article -
17
Abstract 689: Identification and optimization of novel chemical matter via a structure-based approach resulting in a probe for MTH1
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Cancer cells can form reactive oxygen species (ROS) due to altered redox regulation that affect desoxynucleosides triphosphates (dNTP) in particular…”
Get full text
Journal Article -
18
Abstract 1164: Metabolic responses in cancer cells with differential susceptibility to GLUT1 inhibition
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Abstract Malignant cells are known for their accelerated metabolism, high energy requirements, and increased glucose uptake. They are characterized by high…”
Get full text
Journal Article -
19
A Preclinical Study Combining the DNA Repair Inhibitor Dbait with Radiotherapy for the Treatment of Melanoma1
Published in Neoplasia (New York, N.Y.) (23-10-2014)“…Melanomas are highly radioresistant tumors, mainly due to efficient DNA double-strand break (DSB) repair. Dbait (which stands for DNA strand break bait)…”
Get full text
Journal Article -
20
Abstract 1442: Effects of selective and broad glucose transporter (GLUT) inhibition on glucose distribution in tumor bearing mice
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…Abstract Malignant cells are known for their accelerated metabolism, high energy requirements, and increased glucose uptake. Transport of glucose across the…”
Get full text
Journal Article